微信公众号
证券之星APP
| 报告期 | 净资产收益率 | 同比 | 环比 | 行业排名 | 行业均值 | 行业龙头股 | 龙头股该指标值 | 查看 |
|---|---|---|---|---|---|---|---|---|
| 2024-09-30 | 0.41% | -81.61% | -61.68% | 108/160 | 4.14% | 百利天恒 | 186.1% | 行业排名> |
| 2024-06-30 | 1.07% | -28.19% | 52.86% | 101/160 | 2.6% | 百利天恒 | 186.89% | 行业排名> |
| 2024-03-31 | 0.7% | 29.63% | -65.69% | 100/160 | 2.3% | 百利天恒 | 188.56% | 行业排名> |
| 2023-12-31 | 2.04% | 141.46% | -8.52% | 89/160 | -0.96% | 小方制药 | 41.8% | 行业排名> |
| 2023-09-30 | 2.23% | 134.74% | 49.66% | 105/160 | 2.37% | 拓新药业 | 20.51% | 行业排名> |
| 2023-06-30 | 1.49% | -36.86% | 175.93% | 95/160 | 1.51% | 拓新药业 | 19.87% | 行业排名> |
| 2023-03-31 | 0.54% | -85.08% | 110.98% | 109/160 | 1.38% | 拓新药业 | 19.91% | 行业排名> |
| 2022-12-31 | -4.92% | -132.26% | -617.89% | 119/160 | 0.8% | 小方制药 | 55.57% | 行业排名> |
| 2022-09-30 | 0.95% | -91.44% | -59.75% | 107/160 | 2.89% | 福元医药 | 25.41% | 行业排名> |
| 2022-06-30 | 2.36% | -71.84% | -34.81% | 79/160 | 2.24% | 小方制药 | 34.81% | 行业排名> |
| 2022-03-31 | 3.62% | 4.32% | -76.26% | 24/160 | 1.61% | 退市金泰 | 10.74% | 行业排名> |
| 2021-12-31 | 15.25% | -13.2% | 37.39% | 20/160 | 0.94% | 人福医药 | 6.82% | 行业排名> |
| 2021-09-30 | 11.1% | -32.36% | 32.46% | 27/160 | 4.53% | 小方制药 | 71.99% | 行业排名> |
| 2021-06-30 | 8.38% | -35.74% | 141.5% | 22/160 | 2.99% | 汇宇制药 | 39.25% | 行业排名> |
| 2021-03-31 | 3.47% | -22.54% | -80.25% | 33/160 | 2.52% | 汇宇制药 | 28.14% | 行业排名> |
| 2020-12-31 | 17.57% | -1.35% | 7.07% | 28/160 | 3.74% | 哈三联 | 27.17% | 行业排名> |
| 2020-09-30 | 16.41% | 12.4% | 25.84% | 13/160 | 3.22% | 汇宇制药 | 55.94% | 行业排名> |
| 2020-06-30 | 13.04% | 33.06% | 191.07% | 9/160 | 4.24% | 河化股份 | 45.32% | 行业排名> |
| 2020-03-31 | 4.48% | -8.01% | -74.85% | 17/160 | 2.24% | 汇宇制药 | 31.9% | 行业排名> |
| 2019-12-31 | 17.81% | 62.65% | 21.99% | 24/160 | 2.78% | 誉衡药业 | 35.56% | 行业排名> |
| 2019-09-30 | 14.6% | 55.98% | 48.98% | 14/160 | 7.61% | 奥赛康 | 35% | 行业排名> |
| 2019-06-30 | 9.8% | 37.06% | 101.23% | 16/160 | 5.05% | 奥赛康 | 28.15% | 行业排名> |
| 2019-03-31 | 4.87% | 90.98% | -55.53% | 13/160 | 2.46% | 宏源药业 | 21.91% | 行业排名> |
| 2018-12-31 | 10.95% | 52.51% | 16.99% | 47/160 | 7.09% | 奥赛康 | 9.7% | 行业排名> |
| 2018-09-30 | 9.36% | 10.64% | 30.91% | 28/160 | 7.26% | 奥赛康 | 40.69% | 行业排名> |
| 2018-06-30 | 7.15% | 14.95% | 180.39% | 23/160 | 4.65% | 信立泰 | 25.93% | 行业排名> |
| 2018-03-31 | 2.55% | -25% | -64.48% | 41/160 | 2.55% | 昂利康 | 15.91% | 行业排名> |
| 2017-12-31 | 7.18% | -30.29% | -15.13% | 73/160 | 9.66% | 奥赛康 | 12.08% | 行业排名> |
| 2017-09-30 | 8.46% | -8.24% | 36.01% | 39/160 | 8.31% | 一品红 | 31.62% | 行业排名> |
| 2017-06-30 | 6.22% | -17.07% | 82.94% | 34/160 | 5.59% | 丽珠集团 | 49.43% | 行业排名> |
| 2017-03-31 | 3.4% | -38.85% | -66.99% | 20/160 | 2.1% | 河化股份 | 54.24% | 行业排名> |
| 2016-12-31 | 10.3% | -35.42% | 11.71% | 56/160 | 6.33% | 华东医药 | 7.2% | 行业排名> |
| 2016-09-30 | 9.22% | -21.73% | 22.93% | 28/160 | 5.61% | 南新制药 | 81.7% | 行业排名> |
| 2016-06-30 | 7.5% | 2% | 34.89% | 26/160 | 3.53% | 德展健康 | 29.5% | 行业排名> |
| 2016-03-31 | 5.56% | 2% | -65.14% | 10/160 | 2.65% | 贝达药业 | 16.78% | 行业排名> |
| 2015-12-31 | 15.95% | -1.48% | 35.4% | 33/160 | 11.35% | 河化股份 | 19.29% | 行业排名> |
| 2015-09-30 | 11.78% | 2% | -27.24% | 17/160 | 7.22% | 一品红 | 58.17% | 行业排名> |